期刊文献+

超氧化物歧化酶基因多态性及其活力与慢性阻塞性肺疾病的易感性研究 被引量:17

Superoxide dismutase gene polymorphisms and functional activity in chronic obstructive pulmonary disease
原文传递
导出
摘要 目的探讨锰超氧化物歧化酶(Mn-SOD)及细胞外超氧化物歧化酶(EC-SOD)基因多态性与血浆中SOD活力及COPD易感性的相关性。方法收集114例COPD患者(COPD组)和80名健康者(对照组)外周血,提取全血细胞DNA,采用基因测序及限制性片段长度多态性分析检测两组Mn-SOD(G5774A)和EC-SODG(-4466)T基因多态性;提取外周血血浆,检测2组血浆中SOD活力。结果COPD组Mn-SOD的GG、AG和AA基因型频率分别为27.2%(31/114)、53.5%(61/114)和19.3%(22/114),与对照组[46.3%(37/80)、37.5%(30/80)和16.2%(13/80)]比较,差异有统计学意义(X^2=7.681,P〈0.05);COPD组A等位基因频率(46.1%,105/228)显著高于对照组(35.O%,56/160),Mn-SOD5774A等位基因是COPD的易感基因(OR=1.585,95%CI为1.045~2.404,P〈0.05);AG和AA基因型与极重度COPD有相关性(X^2=12.345,P〈0.叭)。COPD组EC-SOD的GG、GT和TT基因型频率分别为76.3%(87/114)、22.8%(26/114)和0.9%(1/114),G、T等位基因频率分别为87.7%(200/228)和12.3%(28/228);对照组GG、GT基因型频率分别为71.3%(57/80)和28.7%(23/80),G、T等位基因频率分别为85.6%(137/160)和14.4%(23/160),未检测到TT基因型,2组间基因型及等位基因频率分布比较,差异均无统计学意义(X。值分别为0.631和0.361,均P〉0.05)。COPD组SOD活力[(84±17)kU/L]明显低于对照组[(109±15)kU/L]。结论Mn.SOD(G5774A)位点基因多态性可能与COPD的易感性相关,Mn-SOD的5774A等位基因可能是COPD的易感基因,AG和AA基因型与极重度COPD有相关性;COPD患者存在SOD活力下降,提示COPD患者存在氧化/抗氧化失衡。 Objective To explore the association of genetic polymorphism of superoxide dismutase (SOD) and superoxide dismutase activity in chronic obstructive pulmonary disease. Methods A total of 114 patients with COPD (the COPD group) and 80 healthy volunteers (the control group) were enrolled in this study. Peripheral blood was taken and whole blood cell genomic DNA was extracted. The genetic polymorphisms of Mn-SOD (G5774A) and EC-SOD G (-4466)T genes were determined by DNA sequencing and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Peripheral blood plasma was collected and the functional activity of SOD was determined by a SOD kit. Results The distribution of the Mn-SOD genotype frequencies (GG, AG, AA) between the patients [ 27.2% (31/114), 53.5% (61/114) and 19.3% (22/114)] and the controls [46.3% (37/80), 37.5% (30/80) and 16.2% (13/80)] were significantly different (X^2 = 7. 681, P 〈0. 05). The A allele gene frequencies of the patients (46. 1% , 105/228) were significant higher than those of the controls (35.0%, 56/160) , and subjects with the A allele gene of Mn-SOD were more likely to have COPD [OR = 1. 585,95% CI ( 1. 045 - 2.404), P 〈 0. 05 ]. The AA and AG genotypes of Mn-SOD were correlated with the most severe COPD (X^2 = 12. 345, P 〈 0. 01 ). The distribution of the EC-SOD genotype frequencies ( GG, GT, TIP) was 76.3% (87/114), 22. 8% (26/114), 0. 9% (1/114) in the patients and 71.3% ( 57/80), 28.7% (23/80), 0% (0/80) in the controls. The allele gene fi'equencies of the EC-SOD (G, T) were 87.7% (200/228), 12. 3% (28/228) in the patients and 85.6% (137/160) , 14.4% (23/160) in the controls. There were no significant differences in the distribution of the different genotypes or allele gene frequencies between the patients and the controls in the EC-SOD genes ( X^2 = 0. 631, P 〉 0. 05 ; X^2 = 0. 36, P 〉 0. 05). The SOD activity of COPD patients [ (84± 17 ) kU/L]was significant lower than that of the healthy controls [ (109 ±15 ) kU/L] . Conclusions Mn-SOD (G5774A) genetic polymorphism is related to the development of COPD. The Mn-SOD 5774A allele gene may be one of the predisposing genes for COPD. The AA and AG genotypes of Mn-SOD were correlated with the most severy COPD. The decrease of blood plasma SOD activity in COPD patients indicates a dysfunction of the oxidant/antioxidant defense system in the disease.
作者 郭锋 况九龙
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2011年第6期424-428,共5页 Chinese Journal of Tuberculosis and Respiratory Diseases
基金 国家科技支撑计划项目(2008BAl68800)
关键词 超氧化物歧化酶 多态现象 遗传 肺疾病 慢性阻塞性 Superoxide dismutase Polymorphism, genetic Pulmonary disease, chronicobstructive
  • 相关文献

参考文献10

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 2Young RP,Hopkins R,Black PN,et al.Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function.Thorax,2006,61:394-399.
  • 3Wang LI,Miller DP,Sai Y,et al.Manganese superoxide dismutase alanine-to-valine polymorphism at codon 16 and lung cancer risk.J Natl Cancer Inst,2001,93:1818-1821.
  • 4Siedlinski M,van Diemen CC,Postma DS,et al.Superoxide dismutases,lung function and bronchial responsiveness in a general population.Eur Respir J,2009,33:986-992.
  • 5von Ahsen N,Oellerich M.The intronic prothrombin 19911A》G polymorphism influences splicing efficiency and modulates effects of the 20210G》A polymorphism on mRNA amount and expression in a stable reporter gene assay system.Blood,2004,103:586-593.
  • 6Shao J,Chen L,Marrs B,et al.SOD2 polymorphisms:unmasking the effect of polymorphism on splicing.BMC Med Genet,2007,8:7.
  • 7Dahl M,Bowler RP,Juul K,et al.Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations.Am J Respir Crit Care Med,2008,178:906-912.
  • 8Hanta I,Kocabas A,Canacankatan N,et al.Oxidant-antioxidant balance in patients with COPD.Lung,2006,184:51-55.
  • 9Daga MK,Chhabra R,Sharma B,et al.Effects of exogenous vitamin E supplementation on the levels of oxidants and antioxidants in chronic obstructive pulmonary disease.J Biosci,2003,28:7-11.
  • 10刘凌云,曾勉,谢灿茂,高景辉,严英硕,卢桂芳,王辉,贺云鹏.慢性阻塞性肺病患者氧化应激状态及其与糖皮质激素受体水平的相关性[J].南方医科大学学报,2008,28(6):992-996. 被引量:12

二级参考文献19

  • 1曾勉,吴健锋,谢灿茂,严英硕,陈冬梅,禤建美.慢性阻塞性肺疾病急性加重期患者规范化痰诱导安全性的初步研究[J].中华结核和呼吸杂志,2005,28(4):238-241. 被引量:45
  • 2有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 3GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
  • 4Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
  • 5Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
  • 6冉丕鑫 王辰 姚婉贞 等.我国部分地区慢性阻塞性肺疾病流行病学研究[J].中华结核和呼吸杂志,2007,.
  • 7Fabbri LM, Hurd SS. Global strategy for the diagnosis, management, and prevention of CDPD: 2003 Update[J]. Eur Resp J, 2003, 22(2): 1-2.
  • 8Celli BR, MacNec W, Agnsti A. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper[ J ]. Eur Respir J, 2004, 23(2): 932-46
  • 9Nowak D, Kalucka S, Bialasiewicz P. Exhalation of H2O2 and thiobarbituric acid reactive substances (TBARs) by healthy subjects [J]. Free Radic Biol Med, 2001, 30(2): 178-86.
  • 10Santos MC, Oliveira AL, Viegas AM, et al. Systemic markers of the redox balance in chronic obstructive pulmonary disease [J]. Biomarkers, 2004, 9(6): 461-9.

共引文献8241

同被引文献139

引证文献17

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部